Healthcare Services

Peripheral Artery Disease Market Revenue Expected to Reach $6.69 Billion by 2030 with 7.8% CAGR

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Peripheral Artery Disease Market Across 2026–2030?

The peripheral artery disease market size has experienced significant expansion in recent years. It is anticipated to increase from $4.62 billion in 2025 to $4.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. The historical growth in this market can be attributed to the high prevalence of peripheral artery disease, limited awareness of PAD risk factors, reliance on traditional medications, inadequate access to interventional specialists, and fragmented patient care pathways.

The peripheral artery disease market size is projected to experience strong growth in the next few years, reaching $6.69 billion in 2030 with a compound annual growth rate (CAGR) of 7.8%. The growth during this forecast period can be attributed to advancements in minimally invasive peripheral interventions, the increasing adoption of drug-eluting balloons and stents, the expansion of hospitals and specialty vascular clinics, rising patient awareness and early detection initiatives, and the growing use of combination therapies, including lifestyle modification and pharmacotherapy. Major trends anticipated in the forecast period include an increasing use of AI for early PAD diagnosis and risk stratification, a rising adoption of cloud-based patient monitoring systems, a growing focus on genomic-guided personalized PAD therapies, an increasing integration of IoT devices for post-intervention tracking, and a rising implementation of smart manufacturing in PAD device production.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Peripheral Artery Disease Market?

The increasing incidence of peripheral artery diseases is anticipated to fuel the expansion of the peripheral artery disease market in the coming years. Peripheral artery disease involves the narrowing or obstruction of arteries located outside the heart, primarily in the legs, leading to reduced blood flow and potential health issues. Treatment for peripheral artery disease assists in mitigating symptoms, improving mobility, and lowering the risk of severe complications, which in turn enhances patients’ overall well-being. For example, in June 2023, the American Heart Association, a US-based nonprofit organization, estimated that this condition impacts between 7 to 12 million individuals in the United States and 200 million people globally. Thus, the growing prevalence of peripheral artery diseases is a significant factor driving the growth of the peripheral artery disease market.

What Segmentation Levels Are Considered In The Peripheral Artery Disease Market?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits For Interventional Procedures, Support Devices

Which Trends Are Shaping The Future Of The Peripheral Artery Disease Market?

Leading companies in the peripheral artery disease (PAD) market are concentrating on developing innovative solutions, such as dissolvable drug-eluting scaffold systems, to address the increasing demand for safer, more enduring, and less invasive treatment options for arterial blockages below the knee. These resorbable scaffold technologies are designed to restore blood flow and then gradually dissolve, offering a key advantage over traditional permanent metallic stents. For instance, in April 2024, Abbott Laboratories, a U.S.-based medical-device company, introduced the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a pioneering dissolvable stent therapy specifically for below-the-knee PAD. This system delivers everolimus, a drug that aids in preventing vessel re-narrowing, while its fully resorbable structure naturally dissolves over time, thereby eliminating the long-term risks associated with metal implants. It provides physicians with an advanced alternative to traditional angioplasty or permanent stenting, particularly benefiting patients with long lesions or critical limb ischemia. By integrating drug delivery with temporary structural support, the Esprit BTK System aims to enhance vessel healing, reduce complications, and expand treatment possibilities in complex PAD cases.

Which Leading Firms Are Contributing To The Growth Of The Peripheral Artery Disease Market?

Major companies operating in the peripheral artery disease market are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Read the full peripheral artery disease market report here:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Which Regions Are Projected To Dominate The Peripheral Artery Disease Market In The Coming Years?

North America was the largest region in the peripheral artery disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Peripheral Artery Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp

Browse Through More Reports Similar to the Global Peripheral Artery Disease Market 2026, By The Business Research Company

Peripheral Artery Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Vascular Devices And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Peripheral Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795